![]() Precision Antibody to Attend and Present at Interphex Regenerative Medicine 2025 in TokyoIn addition to exhibiting at the event, Dr. Jun Hayashi, the Founder & President at Precision Antibody, will be delivering a presentation on 'Fully Human Antibody Development'. Interphex Japan is one of Asia's largest pharma and biopharma industry events, bringing together professionals across drug discovery, manufacturing, and regenerative medicine. Precision Antibody's presence at the event underscores its continued commitment to expanding global collaboration and supporting researchers with rapid, reliable antibody solutions. "We are proud to participate in one of Asia's most impactful life sciences events," said Dr. Hayashi. "As regenerative medicine evolves, the demand for antibodies with therapeutic- Precision Antibody welcomes attendees to connect during the event to explore how its proprietary development process consistently delivers high-affinity, high-specificity antibodies that work right the first time, enabling faster research, reduced timelines, and better outcomes. About Precision Antibody Founded in 2000, Precision Antibody is a U.S.-based biotechnology company specializing in the development of high-affinity, high-specificity monoclonal antibodies. With a commitment to speed, quality, and reliability, Precision Antibody empowers researchers across academia, biotechnology, and the pharmaceutical industry to achieve scientific breakthroughs more quickly. Media Contact: Precision Antibody Dr. Jun Hayashi President Phone: 410-884-4100 Email: info@precisionantibody.com Website: www.precisionantibody.com Event Details: Interphex Regenerative Medicine 2025 Dates: July 9 - 11, 2025 Location: Tokyo Big Sight, Japan Event Website: https://www.interphex.jp/ Contact Precision Antibody Phone: 410-884-4100 Email: info@precisionantibody.com ***@precisionantibody.com End
|
|